TYRP1 mRNA expression in melanoma metastases correlates with clinical outcome

British Journal of Cancer

Volumn 105, Issue 11, 2011, Pages 1726-1732

  Journe, F ^a   Boufker, H I ^a   Van Kempen, L ^b,e   Galibert, M D ^c   Wiedig, M ^a   Sales F ^a   Theunis, A ^a   Nonclercq, D ^d   Frau, A ^d   Laurent, G ^d   Awada, A ^a   Ghanem, G ^a  

^a JULES BORDET INSTITUTE   (Belgium)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITÉ DE RENNES 1   (France)

^d UNIVERSITY OF MONS   (Belgium)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

Breslow; marker; melanoma; prognosis; survival

Indexed keywords

MESSENGER RNA; TYROSINASE RELATED PROTEIN 1;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL EVALUATION; DISTANT METASTASIS FREE SURVIVAL; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTASIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; SKIN METASTASIS;

ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION PROFILING; GENETIC TESTING; HUMANS; LYMPHATIC METASTASIS; MALE; MELANOMA; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDOREDUCTASES; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN NEOPLASMS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 81955167413     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2011.451     Document Type: Article

References (31)

1. Alonzo TA (2005) Standards for reporting prognostic tumor marker studies. J Clin Oncol 23: 9053-9054
2. Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, Buzaid AC, Cochran AJ, Coit DG, Ding S, Eggermont AM, Flaherty KT, Gimotty PA, Kirkwood JM, McMasters KM, Mihm Jr MC, Morton DL, Ross MI, Sober AJ, Sondak VK (2009) Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 27: 6199-6206
3. Bogunovic D, O'Neill DW, Belitskaya-Levy I, Vacic V, Yu YL, Adams S, Darvishian F, Berman R, Shapiro R, Pavlick AC, Lonardi S, Zavadil J, Osman I, Bhardwaj N (2009) Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival. Proc Natl Acad Sci USA 106: 20429-20434
4. Bolander A, Agnarsdottir M, Stromberg S, Ponten F, Hesselius P, Uhlen M, Bergqvist M (2008) The protein expression of TRP-1 and galectin-1 in cutaneous malignant melanomas. Cancer Genomics Proteomics 5: 293-300
5. Chen H, Salopek TG, Jimbow K (2001) The role of phosphoinositide 3-kinase in the sorting and transport of newly synthesized tyrosinaserelated protein-1 (TRP-1). J Investig Dermatol Symp Proc 6: 105-114 (Pubitemid 33758614)
6. Fang D, Hallman J, Sangha N, Kute TE, Hammarback JA, White WL, Setaluri V (2001) Expression of microtubule-associated protein 2 in benign and malignant melanocytes: implications for differentiation and progression of cutaneous melanoma. Am J Pathol 158: 2107-2115 (Pubitemid 32545196)
7. Haqq C, Nosrati M, Sudilovsky D, Crothers J, Khodabakhsh D, Pulliam BL, Federman S, Miller 3rd JR, Allen RE, Singer MI, Leong SP, Ljung BM, Sagebiel RW, Kashani-Sabet M (2005) The gene expression signatures of melanoma progression. Proc Natl Acad Sci USA 102: 6092-6097 (Pubitemid 40594260)
8. Hearing VJ, Tsukamoto K, Urabe K, Kameyama K, Montague PM, Jackson IJ (1992) Functional properties of cloned melanogenic proteins. Pigment Cell Res 5: 264-270
9. Hoek KS (2007) DNA microarray analyses of melanoma gene expression: a decade in the mines. Pigment Cell Res 20: 466-484 (Pubitemid 47568833)
10. Hofmann-Wellenhof R, Woltsche-Kahr I, Smolle J, Kerl H (1996) Clinical and histological features of poor prognosis in cutaneous metastatic melanomas. J Cutan Pathol 23: 199-204 (Pubitemid 26181306)
11. Jimbow K, Gomez PF, Toyofuku K, Chang D, Miura S, Tsujiya H, Park JS (1997) Biological role of tyrosinase related protein and its biosynthesis and transport from TGN to stage I melanosome, late endosome, through gene transfection study. Pigment Cell Res 10: 206-213 (Pubitemid 127524182)
12. John T, Black MA, Toro TT, Leader D, Gedye CA, Davis ID, Guilford PJ, Cebon JS (2008) Predicting clinical outcome through molecular profiling in stage III melanoma. Clin Cancer Res 14: 5173-5180
13. Larson AR, Konat E, Alani RM (2009) Melanoma biomarkers: current status and vision for the future. Nat Clin Pract Oncol 6: 105-117
14. Lomas J, Martin-Duque P, Pons M, Quintanilla M (2008) The genetics of malignant melanoma. Front Biosci 13: 5071-5093 (Pubitemid 351599659)
15. Mandruzzato S, Callegaro A, Turcatel G, Francescato S, Montesco MC, Chiarion-Sileni V, Mocellin S, Rossi CR, Bicciato S, Wang E, Marincola FM, Zanovello P (2006) A gene expression signature associated with survival in metastatic melanoma. J Transl Med 4: 50
16. Mattes MJ, Thomson TM, Old LJ, Lloyd KO (1983) A pigmentationassociated, differentiation antigen of human melanoma defined by a precipitating antibody in human serum. Int J Cancer 32: 717-721 (Pubitemid 14214916)
17. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM (2005) Reporting recommendations for tumor marker prognostic studies. J Clin Oncol 23: 9067-9072
18. Murisier F, Beermann F (2006) Genetics of pigment cells: lessons from the tyrosinase gene family. Histol Histopathol 21: 567-578
19. Nagore E, Oliver V, Botella-Estrada R, Moreno-Picot S, Insa A, Fortea JM (2005) Prognostic factors in localized invasive cutaneous melanoma: high value of mitotic rate, vascular invasion and microscopic satellitosis. Melanoma Res 15: 169-177 (Pubitemid 40839464)
20. Patel D, Balderes P, Lahiji A, Melchior M, Ng S, Bassi R, Wu Y, Griffith H, Jimenez X, Ludwig DL, Hicklin DJ, Kang X (2007) Generation and characterization of a therapeutic human antibody to melanoma antigen TYRP1. Hum Antibodies 16: 127-136 (Pubitemid 351359902)
21. Rad HH, Yamashita T, Jin HY, Hirosaki K, Wakamatsu K, Ito S, Jimbow K (2004) Tyrosinase-related proteins suppress tyrosinase-mediated cell death of melanocytes and melanoma cells. Exp Cell Res 298: 317-328 (Pubitemid 38950851)
22. Sarangarajan R, Zhao Y, Babcock G, Cornelius J, Lamoreux ML, Boissy RE (2000) Mutant alleles at the brown locus encoding tyrosinase-related protein-1 (TRP-1) affect proliferation of mouse melanocytes in culture. Pigment Cell Res 13: 337-344
23. Savoia P, Fava P, Nardo T, Osella-Abate S, Quaglino P, Bernengo MG (2009) Skin metastases of malignant melanoma: a clinical and prognostic survey. Melanoma Res 19: 321-326
24. Schlagenhauff B, Stroebel W, Ellwanger U, Meier F, Zimmermann C, Breuninger H, Rassner G, Garbe C (1997) Metastatic melanoma of unknown primary origin shows prognostic similarities to regional metastatic melanoma: recommendations for initial staging examinations. Cancer 80: 60-65 (Pubitemid 27270920)
25. Soltani MH, PichardoR, Song Z, Sangha N, Camacho F, Satyamoorthy K, Sangueza OP, Setaluri V (2005) Microtubule-associated protein 2, a marker of neuronal differentiation, induces mitotic defects, inhibits growth of melanoma cells, and predicts metastatic potential of cutaneous melanoma. Am J Pathol 166: 1841-1850 (Pubitemid 40734406)
26. Takechi Y, Hara I, Naftzger C, Xu Y, Houghton AN (1996) A melanosomal membrane protein is a cell surface target for melanoma therapy. Clin Cancer Res 2: 1837-1842 (Pubitemid 26384150)
27. Vijayasaradhi S, Doskoch PM, Wolchok J, Houghton AN (1995) Melanocyte differentiation marker gp75, the brown locus protein, can be regulated independently of tyrosinase and pigmentation. J Invest Dermatol 105: 113-119
28. Wasmeier C, Romao M, Plowright L, Bennett DC, Raposo G, Seabra MC (2006) Rab38 and Rab32 control post-Golgi trafficking of melanogenic enzymes. J Cell Biol 175: 271-281 (Pubitemid 44631421)
29. Watabe H, Valencia JC, Yasumoto K, Kushimoto T, Ando H, Muller J, Vieira WD, Mizoguchi M, Appella E, Hearing VJ (2004) Regulation of tyrosinase processing and trafficking by organellar pH and by proteasome activity. J Biol Chem 279: 7971-7981 (Pubitemid 38294685)
30. Wellbrock C, Rana S, Paterson H, Pickersgill H, Brummelkamp T, Marais R (2008) Oncogenic BRAF regulates melanoma proliferation through the lineage specific factor MITF. PLoS One 3: e2734
31. Winnepenninckx V, Lazar V, Michiels S, Dessen P, Stas M, Alonso SR, Avril MF, Ortiz Romero PL, Robert T, Balacescu O, Eggermont AM, Lenoir G, Sarasin A, Tursz T, van den Oord JJ, Spatz A (2006) Gene expression profiling of primary cutaneous melanoma and clinical outcome. J Natl Cancer Inst 98: 472-482